Castle Biosciences (CSTL) Notes Payables (2019)
Castle Biosciences (CSTL) posted Notes Payables of $4.4 million for Q2 2019.
Castle Biosciences (CSTL) Notes Payables (2019) Analysis & Trends
Castle Biosciences has reported Notes Payables for 1 years, with the latest figure at $4.4 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn |
| 10 | Castle Biosciences | 923.37 Mn | 656.55 Mn | 79.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 4.43 Mn |